Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 3Enterogermina
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2019 Revenue in Millions : 242
2018 Revenue in Millions : 199
Growth (%) : 21
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2020 Revenue in Millions : 218
2019 Revenue in Millions : 269
Growth (%) : -19
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2018 Revenue in Millions : 207
2017 Revenue in Millions : 190
Growth (%) : 9%
LOOKING FOR A SUPPLIER?